Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M289,106Revenue $M71,312Net Margin (%)19.4Z-Score5.2
Enterprise Value $M277,005EPS $4.8Operating Margin %25.8F-Score7
P/E(ttm))19.3Cash Flow Per Share $6.2Pre-tax Margin (%)21.7Higher ROA y-yY
Price/Book3.710-y EBITDA Growth Rate %3.5Quick Ratio2.1Cash flow > EarningsY
Price/Sales4.15-y EBITDA Growth Rate %-0.9Current Ratio2.4Lower Leverage y-yN
Price/Cash Flow11.3y-y EBITDA Growth Rate %19.6ROA % (ttm)10.4Higher Current Ratio y-yY
Dividend Yield %2.6Insider Buy (3m)0ROE % (ttm)18.7Less Shares Outstanding y-yN
Payout Ratio %51.0Shares Outstanding M2,829ROI % (ttm)15.4Gross Margin Increase y-yY

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 56.

JNJ is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
JNJ Yacktman Fund 2014-06-304,050,0000.143.6
JNJ Yacktman Focused Fund 2014-06-303,300,0000.123.5-13.16%
JNJ George Soros 2014-03-31102,50000.1New Buy
JNJ Joel Greenblatt 2014-03-317,49600.01New Buy
JNJ Ray Dalio 2014-03-31262,9930.010.21+132.34%
JNJ Ruane Cunniff 2014-03-3175,79400.04+2.29%
JNJ Jean-Marie Eveillard 2014-03-311,617,5670.060.42+0.64%
JNJ Prem Watsa 2014-03-3184,70000.58
JNJ Michael Price 2014-03-3135,00000.42
JNJ Warren Buffett 2014-03-31327,1000.010.03
JNJ Dodge & Cox 2014-03-3138,62500
JNJ Richard Perry 2014-03-31342,2770.010.94
JNJ Donald Yacktman 2014-03-319,572,8500.343.9-0.39%
JNJ Tweedy Browne 2014-03-314,269,2060.159.7-0.85%
JNJ Tom Gayner 2014-03-31574,2000.021.7-1.1%
JNJ James Barrow 2014-03-3116,953,0290.62.4-2.18%
JNJ Mario Gabelli 2014-03-31395,0610.010.21-4.06%
JNJ PRIMECAP Management 2014-03-3112,300,9860.431.4-10.14%
JNJ John Hussman 2014-03-312,65000.02-97.42%
JNJ Meridian Funds 2013-06-307,88500.03
Premium Most recent portfolio changes are included for Premium Members only!

JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
COSGROVE STEPHEN JCorporate Controller 2014-05-05Sell22,000$100.052.42view
Fasolo PeterVP, Global Human Resources 2014-03-14Sell6,824$93.1510.01view
COSGROVE STEPHEN JCorporate Controller 2013-08-14Sell17,200$91.3912.12view
Ullmann Michael HVP, General Counsel 2013-08-05Sell16,140$93.689.38view
Stoffels PaulusChief Scientific Officer 2013-07-25Sell45,440$92.410.9view
Caruso Dominic JVP, Finance; CFO 2013-07-18Sell30,000$90.3113.46view
CULLEN JAMESDirector 2013-05-07Sell4,929$85.419.99view
LINDQUIST SUSAN LDirector 2012-12-07Sell7,600$70.0246.34view
CULLEN JAMESDirector 2012-11-12Sell13,900$69.747.02view
Caruso Dominic JCFO 2012-10-19Sell20,400$71.9542.42view

Press Releases about JNJ :

    Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    Top Five Mega-Cap Stocks That Gurus Like Jun 25 2014 
    Pharma Sector Stocks To Consider For Sustained Returns Jun 25 2014 
    Running an Offense or Defense? Jun 22 2014 
    The Split That Makes Me Want More Jun 20 2014 
    Investors May Add Johnson & Johnson to Their Portfolio Jun 16 2014 
    Health Care Sector in an Upward Climb in June Jun 12 2014 
    'Extreme Patience' One Month at a Time Jun 04 2014 
    My 5 Largest Dividend Stock Positions Have Double-Digit Lifetime Returns Jun 04 2014 
    Outlook for June 2014 Jun 02 2014 
    Johnson & Johnson (JNJ) Dividend Stock Analysis May 29 2014 

    More From Other Websites
    Alexion, 3 Other Top Biotechs Reporting Earnings Jul 22 2014
    Why Johnson & Johnson (JNJ) Stock Is Up Today Jul 22 2014
    J&J buying back $5 billion worth of its shares Jul 21 2014
    J&J buying back $5 billion worth of its shares Jul 21 2014
    [$$] J&J Adds $5 Billion to Stock Buyback Program Jul 21 2014
    Johnson & Johnson sets $5 billion share buyback Jul 21 2014
    JOHNSON & JOHNSON Files SEC form 8-K, Other Events Jul 21 2014
    [video] Johnson & Johnson announces buyback program Jul 21 2014
    Johnson & Johnson Announces $5 Billion Share Repurchase Program Jul 21 2014
    5:00 pm Johnson & Johnson announced that its Board of Directors has approved the repurchase of up to... Jul 21 2014
    Johnson & Johnson (JNJ) Declares 70c Quarterly Dividend Jul 21 2014
    Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2014 Jul 21 2014
    Gilead Drug Combination Cures Hepatitis C in HIV Patients Jul 20 2014
    Why Has Wall Street Punished Johnson & Johnson For Its Earnings Beat? Jul 18 2014

    Add Notes, Comments or Ask Questions

    User Comments

    ReplyGurufocus - 9 months ago
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    Email Hide